Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • question about RNA-Seq and strandness information

    Hi,
    I'm fairly new to RNA-Seq data analysis and I'm a bit confused about something and I'd like to get your views on it. I have run an RNA-Seq analysis for a set of samples that i have been told they were prepared as second strand. So I've run tophat2 (didn't include strandness there, left if as default), then I counted reads with HTSeq (using -s reverse), and done DESeq and DEXSeq. I was happy with my data, since I could detect our positive control splicing events, until I had to run another data set, and something went wrong.
    I've contacted the people that had prepared the libraries and run the sequencing for us and it turns out that the first data set had to be run using fr-firststrand.
    Now I'm very confused, why does my analysis show differential splicing in positive control splicing events, if it seems that i have run the wrong commands? is the fact that I run the mapping as default the explanation? but then how about counting with HTSeq? surely that should be counting the wrong strand and throwing away a lot of useful data?

    I would appreciate if anyone could help, i'm extremely confused here.

    Thank you very much for your time and help,

    Miriam

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    09-09-2024, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 09-11-2024, 02:44 PM
0 responses
11 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-06-2024, 08:02 AM
0 responses
145 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-03-2024, 08:30 AM
0 responses
152 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-27-2024, 04:40 AM
0 responses
161 views
0 likes
Last Post seqadmin  
Working...
X